A pilot study the effectiveness of immune globulin for ALI / ARDS

Not Applicable

• Conditions: ALI/ARDS due to sepsis

• Registration Number: JPRN-UMIN000005422
• Lead Sponsor: Division of Respirology, department of internal medicine, Jikei University Hospital

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2011-04-12
• Study Completion: 2012-12-01
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Complete: follow-up complete
• Sex: All
• Target Recruitment: 10

Inclusion Criteria

Not provided

Exclusion Criteria

1) Patients with a history of allergy or shock to the components of the immune globulin 2) Patients with severe liver damage (for example: patients with cirrhosis), however, derived from liver failure include sepsis. 3) Patients with severe renal failure (for example: chronic dialysis patients), however, derived from kidney failure include sepsis. 4) Patients with sepsis due to hematological malignancies 5) Patients in the treatment of malignant tumors 6) Patients treated with immunosuppressive drugs such as cyclosporine 7) Patients with less than 1000 granulocytes / mm2 due to any reasons other than sepsis 8) Patients who develop chronic heart failure or acute myocardial infarction within the last six weeks 9) Patients who are judged to be inappropriate by doctor

Study & Design

• Study Type: Interventional
• Study Design: Not specified